Table 4

Echocardiographic and biohumoral changes from baseline to follow-up.

Baseline (mean; SD)FU (mean; SD)Pairwise complete observationsMean differencep Value*95% CI
LVEF0.48; 0.190.48; 0.16770NS−0.63 to 0.6
LVEDV (ml)158; 92137; 6352160.000227.9 to 24.0
LVESV (ml)93; 8485; 675290.021.5 to 16.5
EDVI (ml/m2)87; 4879; 395290.000284.4 to 13.6
LVEDD (mm)58.6; 12.155.8; 11.1411.60.030.1 to 3.1
LVESD (mm)43.2; 15.841.4; 14.0362.10.06−0.1 to 4.3
LA diameter (mm)51; 1149; 9650NS−1.63 to 1.6
RV-RA gradient (mm Hg)47; 1539; 156270.00142.6 to 10.6
nt-proBNP (ng/l)4474; 58852499; 34082711260.0398.5 to 2153.5
  • Data are given as mean±SD.

  • *p Value for between group comparisons of mean changes (only pairwise complete observations).

  • FU has been performed between 6 and 12 months after MitraClip implantation.

  • EDVI, end-diastolic volume index; LA, left atrium; LVEDD, left ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; LVESV, left ventricular end-systolic volume: RA, right atrium; RV, right ventricle.